JP2003529046A - 血栓症鬱血の検査データを提示するための方法及び装置 - Google Patents

血栓症鬱血の検査データを提示するための方法及び装置

Info

Publication number
JP2003529046A
JP2003529046A JP2001507105A JP2001507105A JP2003529046A JP 2003529046 A JP2003529046 A JP 2003529046A JP 2001507105 A JP2001507105 A JP 2001507105A JP 2001507105 A JP2001507105 A JP 2001507105A JP 2003529046 A JP2003529046 A JP 2003529046A
Authority
JP
Japan
Prior art keywords
curve
unknown
time
sample
data
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001507105A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003529046A5 (enExample
Inventor
ギヴンズ，トーマス・ビー
ブラウン，ポール
ベック，リサ
Original Assignee
アクゾ・ノーベル・ナムローゼ・フェンノートシャップ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アクゾ・ノーベル・ナムローゼ・フェンノートシャップ filed Critical アクゾ・ノーベル・ナムローゼ・フェンノートシャップ
Publication of JP2003529046A publication Critical patent/JP2003529046A/ja
Publication of JP2003529046A5 publication Critical patent/JP2003529046A5/ja
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/49—Blood
    • G01N33/4905—Determining clotting time of blood
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/22—Haematology
    • G01N2800/224—Haemostasis or coagulation
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/22—Haematology
    • G01N2800/226—Thrombotic disorders, i.e. thrombo-embolism irrespective of location/organ involved, e.g. renal vein thrombosis, venous thrombosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/38—Pediatrics
    • G01N2800/385—Congenital anomalies
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H70/00—ICT specially adapted for the handling or processing of medical references
    • G16H70/60—ICT specially adapted for the handling or processing of medical references relating to pathologies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Ecology (AREA)
  • Biophysics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
JP2001507105A 1999-06-30 2000-06-30 血栓症鬱血の検査データを提示するための方法及び装置 Pending JP2003529046A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/345,080 1999-06-30
US09/345,080 US6502040B2 (en) 1997-12-31 1999-06-30 Method for presenting thrombosis and hemostasis assay data
PCT/US2000/018310 WO2001001152A1 (en) 1999-06-30 2000-06-30 Method and apparatus for presenting thrombosis and hemostasis assay data

Publications (2)

Publication Number Publication Date
JP2003529046A true JP2003529046A (ja) 2003-09-30
JP2003529046A5 JP2003529046A5 (enExample) 2007-07-05

Family

ID=23353417

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001507105A Pending JP2003529046A (ja) 1999-06-30 2000-06-30 血栓症鬱血の検査データを提示するための方法及び装置

Country Status (10)

Country Link
US (1) US6502040B2 (enExample)
EP (1) EP1188060B1 (enExample)
JP (1) JP2003529046A (enExample)
KR (1) KR20020042539A (enExample)
AT (1) ATE328327T1 (enExample)
AU (1) AU768436B2 (enExample)
CA (1) CA2377528C (enExample)
DE (1) DE60028374T2 (enExample)
ES (1) ES2270850T3 (enExample)
WO (1) WO2001001152A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1436628A2 (en) * 2001-06-29 2004-07-14 BioMerieux, Inc. A method for predicting an increased likelihood of antiphospholipid syndrome in a patient
US9125989B2 (en) 2003-01-23 2015-09-08 Debiotech S.A. Device for determining the characteristics of peritoneal membrane
US20050089994A1 (en) * 2002-01-28 2005-04-28 Frederic Neftel Peritoneal dialysis system
ES1063877Y (es) 2006-10-02 2007-03-16 Lafuente Flo Rosa Funda perfeccionada para cascos de motocicleta
US8548935B2 (en) * 2008-02-14 2013-10-01 Orion Diagnostica Oy Predicting a future property using reagents by measuring properties at points in time
WO2009135205A2 (en) * 2008-05-02 2009-11-05 Advanced Liquid Logic, Inc. Droplet actuator techniques using coagulatable samples
US20090298103A1 (en) * 2008-05-20 2009-12-03 The University Of Vermont And State Agriculture College Predicting hemostatic risk; dependence on plasma composition
JP5982976B2 (ja) * 2012-04-13 2016-08-31 ソニー株式会社 血液凝固系解析装置、血液凝固系解析方法及びそのプログラム

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0559415A (ja) * 1991-09-02 1993-03-09 Kobe Steel Ltd 高炉炉熱変化推定装置
JPH06176002A (ja) * 1992-07-25 1994-06-24 Boehringer Mannheim Gmbh 医学的試料中の成分の分析法
JPH11507131A (ja) * 1995-06-07 1999-06-22 アクゾ・ノベル・エヌ・ベー 先天性および後天性平衡失調ならびにその治療状態の存在を予測する方法および装置

Family Cites Families (90)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3307392A (en) 1964-05-04 1967-03-07 Research Corp Automatic prothrombin timer apparatus and method
US3458287A (en) 1965-04-29 1969-07-29 Medical Laboratory Automation Method and means of determining endpoint times in blood clotting tests
US3658480A (en) 1970-04-13 1972-04-25 Bio Data Corp Coagulation timing apparatus, and method
US4047890A (en) 1973-11-01 1977-09-13 Bio/Data Corporation Method and apparatus for determining deficiencies in enzymatic reactors particularly clotting factor levels in blood plasmas
SU590665A1 (ru) 1976-02-11 1978-01-30 Новосибирский государственный медицинский институт Способ исследовани процесса свертывани крови
US4040788A (en) 1976-04-05 1977-08-09 Sanford L. Simons Apparatus, instrumentation, and method for comparing samples
DE2635081C3 (de) 1976-08-04 1980-08-07 Bio/Data Corp., Willow Grove, Pa. (V.St.A.) Verfahren und Vorrichtung zur Bestimmung von Blutplasma-Gerinnungsfaktorpegeln
FR2364453A1 (fr) 1976-09-08 1978-04-07 Lacombe Pierre Dispositif electronique apportant un perfectionnement aux appareils destines a analyser la coagulation sanguine : prothrombinometre citrate-oxalate
US4199748A (en) 1976-11-01 1980-04-22 Rush-Presbyterian-St. Luke's Medical Center Automated method and apparatus for classification of cells with application to the diagnosis of anemia
JPS5451893A (en) 1977-09-30 1979-04-24 Sankyo Co Measuring of blood coagulating time
JPS5822703B2 (ja) 1978-08-30 1983-05-10 三共株式会社 血液凝固測定方法
US4289498A (en) 1979-01-08 1981-09-15 Ortho Diagnostics, Inc. One-stage prothrombin assay and compositions useful therein
US4766083A (en) 1982-04-04 1988-08-23 Wako Pure Chemical Industries, Ltd. Method for the photometric determination of biological agglutination
SU1076086A1 (ru) 1982-12-28 1984-02-29 Всесоюзный Научно-Исследовательский И Конструкторский Институт Медицинской Лабораторной Техники Гемокоагулограф
EP0115459A3 (en) 1983-01-26 1986-11-20 University Of Medicine And Dentistry Of New Jersey Hematological prediction of sepsis and other disease states
US4705756A (en) 1983-01-26 1987-11-10 University Of Medicine And Dentistry Of New Jersey Method of determining the existence and/or the monitoring of a pathological condition in a mammal
JPS59203959A (ja) 1983-05-04 1984-11-19 Toa Medical Electronics Co Ltd 血液凝固時間測定装置
JPH0695095B2 (ja) 1983-11-25 1994-11-24 株式会社島津製作所 全自動血液分析装置
DE3502878A1 (de) 1985-01-29 1986-07-31 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur bestimmung des fibrinolytischen zustands von plasma
JPS61272655A (ja) 1985-05-28 1986-12-02 Iryo Kogaku Kenkyusho:Kk 血小板凝集能の定量的判定方法
GB8516081D0 (en) 1985-06-25 1985-07-31 Ciba Geigy Ag Assay & purification of amyloid components
US4902630A (en) 1985-07-22 1990-02-20 Abbott Laboratories Fluorescence polarization immunoassy and reagents for measurement of c-reactive protein
US5593897A (en) 1988-04-04 1997-01-14 Northwestern University Binding of immune complexes by modified forms of C-reactive protein
AU633488B2 (en) 1988-04-04 1993-02-04 Northwestern University Binding of immune complexes by modified forms of c-reactive protein
US4965725B1 (en) 1988-04-08 1996-05-07 Neuromedical Systems Inc Neural network based automated cytological specimen classification system and method
US5156974A (en) 1988-05-27 1992-10-20 Biodata Corporation Method for determining the fibrinogen level of a blood sample
US5003065A (en) 1988-06-14 1991-03-26 Carey Merritt Compounds and process for measuring c-reactive protein
US5697369A (en) * 1988-12-22 1997-12-16 Biofield Corp. Method and apparatus for disease, injury and bodily condition screening or sensing
US5055412A (en) 1989-03-21 1991-10-08 Proksch Gary J Factor sensitive reagent for testing of blood coagulation containing ellagic acid and divalent metal ions and method of making the same
US5500345A (en) 1989-04-25 1996-03-19 Iatron Laboratories, Inc. Hybridomas producing monoclonal antibodies specific for C-reactive protein and methods for detection of C-reactive protein
JPH04505857A (ja) 1989-06-27 1992-10-15 ラッシュ―プレズビティリアン―セント　ルークス　メディカル　センター Ｃ反応性蛋白質に対するモノクローナル抗体
WO1991001383A1 (en) 1989-07-14 1991-02-07 Michigan State University Method for diagnosing blood clotting disorders
US5051357A (en) 1989-07-14 1991-09-24 Board Of Trustees Operating Michigan State University Method and assay using inactivation of factors Va and VIIIa by activated Protein C to diagnose thrombic disease or assay for Protein C and kit therefor
EP0482088B1 (en) 1989-07-20 1999-03-31 Analytical Control Systems, Inc. Improved stable coagulation controls
SU1691741A1 (ru) 1989-08-25 1991-11-15 Донецкий государственный медицинский институт Способ прогнозировани геморрагических осложнений при травматической болезни
US4998535A (en) 1989-09-05 1991-03-12 Univ. of Washington New England Medical Center Hospitals, Inc. Thrombolysis predictive instrument
US5262303A (en) 1989-10-13 1993-11-16 Trustees Of Boston University Ligand/anti-ligand assays for adherent proteins
IE904244A1 (en) 1989-12-01 1991-06-05 Akzo Nv Direct fibrinogen assay
US5646046A (en) 1989-12-01 1997-07-08 Akzo Nobel N.V. Method and instrument for automatically performing analysis relating to thrombosis and hemostasis
US5169786A (en) 1989-12-19 1992-12-08 Ortho Diagnostic Systems, Inc. Method of determining levels of extrinsic and intrinsic clotting factors and protein c
JPH05506309A (ja) 1990-04-17 1993-09-16 アナリティカル・コントロール・システムズ・インコーポレーテッド 凝固アッセイおよび試薬
US5862304A (en) 1990-05-21 1999-01-19 Board Of Regents, The University Of Texas System Method for predicting the future occurrence of clinically occult or non-existent medical conditions
US5218529A (en) 1990-07-30 1993-06-08 University Of Georgia Research Foundation, Inc. Neural network system and methods for analysis of organic materials and structures using spectral data
JPH04254760A (ja) 1991-01-30 1992-09-10 Eiken Chem Co Ltd 血清アミロイドａ標準物質、およびその設定方法
US5221628A (en) 1991-03-19 1993-06-22 Northwestern University Binding of aggregated immunoglobulin or immune complexes by serum amyloid P component
RU2012877C1 (ru) 1991-04-01 1994-05-15 Белорусский научно-исследовательский институт охраны материнства и детства Способ прогнозирования синдрома дыхательных расстройств у недоношенных новорожденных
DE69122752T2 (de) 1991-08-02 1997-04-10 Grifols Grupo Sa Verfahren und Vorrichtung zur Bestimmung der Gerinnungszeit von Blut und Plasma
US5716795A (en) 1991-10-04 1998-02-10 Matschiner; John T. Thrombomodulin-based coagulometric assay of the protein C system
AU2870992A (en) 1991-10-04 1993-05-03 Board Of Regents Of The University Of Nebraska, The A soluble thrombomodulin-based one-stage assay for vitamin k-dependent coagulation-inhibiting proteins
WO1993009438A1 (en) 1991-11-04 1993-05-13 Adeza Biomedical Corporation Screening method for identifying women at increased risk for preterm delivery
JPH05180835A (ja) 1991-12-27 1993-07-23 S R L:Kk ループスアンチコアグラントの測定方法
US5318958A (en) 1992-05-29 1994-06-07 Queen's University At Kingston Amyloid precursor protein
JP2934557B2 (ja) 1992-07-10 1999-08-16 国際試薬株式会社 血液凝固時間測定方法とその装置
JPH0636061A (ja) 1992-07-21 1994-02-10 Fujitsu Ltd 階層型ニューラルネットワークの学習方式
US5388164A (en) 1992-08-19 1995-02-07 Olympus Optical Co., Ltd. Method for judging particle agglutination patterns using neural networks
JP3224607B2 (ja) 1992-09-11 2001-11-05 株式会社アズウェル 血液凝固第ｘｉｉｉ因子活性測定方法および該測定用試薬キット
US5369484A (en) 1992-11-09 1994-11-29 Akzo N.V. Multiple discrete analyzer test apparatus and method
US5358852A (en) 1992-12-21 1994-10-25 Eastman Kodak Company Use of calcium in immunoassay for measurement of C-reactive protein
RU2070327C1 (ru) 1992-12-25 1996-12-10 Безруков Александр Васильевич Устройство для измерения времени свертывания крови
US5344754A (en) 1993-01-13 1994-09-06 Avocet Medical, Inc. Assay timed by electrical resistance change and test strip
JP2938302B2 (ja) 1993-02-25 1999-08-23 国際試薬株式会社 血液凝固時間測定方法とその装置
JPH06249857A (ja) 1993-02-26 1994-09-09 Hitachi Ltd 自動分析装置
RU2061953C1 (ru) 1993-03-10 1996-06-10 Тюменский государственный медицинский институт МЗ РФ Способ количественного определения общей коагуляционной активности тромбоцитов
US5670329A (en) 1993-05-28 1997-09-23 Cardiovascular Diagnostics, Inc. Method and analytical system for performing fibrinogen assays accurately, rapidly and simply using a rotating magnetic field
AU688365B2 (en) 1993-08-16 1998-03-12 Biomerieux, Inc. Method and instrument for automatically performing analysis relating to thrombosis and hemostasis
US5526111A (en) 1993-08-31 1996-06-11 Boehringer Mannheim Corporation Method and apparatus for calculating a coagulation characteristic of a sample of blood a blood fraction or a control
US5472852A (en) 1993-09-15 1995-12-05 Oklahoma Medical Research Foundation Assay for detection of selective Protein C inhibition by patients
US5473732A (en) 1993-11-02 1995-12-05 Chang; Hou-Mei H. Relational artificial intelligence system
US5553616A (en) 1993-11-30 1996-09-10 Florida Institute Of Technology Determination of concentrations of biological substances using raman spectroscopy and artificial neural network discriminator
US5856114A (en) * 1994-03-21 1999-01-05 The University Of Vermont Immunologic detection of factor VA fragments in hemorrhagic and thrombotic clinical settings
WO1995030154A1 (en) 1994-04-28 1995-11-09 Dade International Inc. Calibrator for prothrombin time (pt) assays
WO1996006624A1 (en) 1994-08-26 1996-03-07 Immtech International, Inc. A mutant protein and methods and materials for making and using it
US5504011A (en) 1994-10-21 1996-04-02 International Technidyne Corporation Portable test apparatus and associated method of performing a blood coagulation test
SE9403833D0 (sv) 1994-11-08 1994-11-08 Global Hemostasis Inst Mgr Ab Analysförfarande och kit
US5705395A (en) 1994-11-14 1998-01-06 The Scripps Research Institute Method for diagnosis of thrombotic disorders
US5567596A (en) 1994-12-29 1996-10-22 Research Foundation Of State University Of New York Rapid assay of activators and inhibitors of clotting
US6207399B1 (en) 1995-01-10 2001-03-27 Hendrik Coenraad Hemker Methods of determining endogenous thrombin potential (ETP) and thrombin substrates for use in said methods
US6321164B1 (en) 1995-06-07 2001-11-20 Akzo Nobel N.V. Method and apparatus for predicting the presence of an abnormal level of one or more proteins in the clotting cascade
US5780255A (en) 1995-06-09 1998-07-14 Instrumentation Laboratory, S.P.A. Protein C pathway screening test
ATE190728T1 (de) 1995-07-21 2000-04-15 Trinity College Dublin Verfahren zur quantitativen bestimmung menschlichen akutphasen-serum-amyloid-a-proteins; rekombinantes protein; spezifischer antikörper
US5766869A (en) 1995-11-30 1998-06-16 Ahs Hospital Corp. Factor V ratio blood test for susceptibility to thromboembolism
EP0827425B1 (en) 1996-03-22 2004-11-03 Dade Behring Inc. Combination reagent holding and test device
JPH1026621A (ja) 1996-07-12 1998-01-27 Dai Ichi Pure Chem Co Ltd イムノアッセイ法
US5684007A (en) 1996-09-05 1997-11-04 Otsuka Pharmaceutical Co., Ltd. Methods for inhibiting cardiac fibroblast growth and cardiac fibrosis
JP3876022B2 (ja) 1996-09-26 2007-01-31 生化学工業株式会社 血液凝固時間に影響を与える物質の定量方法
US5981285A (en) 1996-10-21 1999-11-09 Carroll; Wallace E. Method and apparatus for determining anticoagulant therapy factors
EP0841566A1 (en) 1996-11-11 1998-05-13 Pentapharm A.G. Positive control plasma for lupus anticoagulant
ES2374621T3 (es) 1997-04-02 2012-02-20 The Brigham And Women's Hospital, Inc. Medios para evaluar el perfil de riesgo de un individuo de sufrir una enfermedad ateroesclerótica.
US6010911A (en) 1997-04-30 2000-01-04 Medtronic, Inc. Apparatus for performing a heparin-independent high sensitivity platelet function evaluation technique
DK0947585T3 (da) 1998-03-19 2001-10-01 Instrumentation Lab Spa Forbedret in vitro-fremgangsmåde, kits og reagenser til screening for blodkoagulationsdefekter

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0559415A (ja) * 1991-09-02 1993-03-09 Kobe Steel Ltd 高炉炉熱変化推定装置
JPH06176002A (ja) * 1992-07-25 1994-06-24 Boehringer Mannheim Gmbh 医学的試料中の成分の分析法
JPH11507131A (ja) * 1995-06-07 1999-06-22 アクゾ・ノベル・エヌ・ベー 先天性および後天性平衡失調ならびにその治療状態の存在を予測する方法および装置

Also Published As

Publication number Publication date
DE60028374D1 (de) 2006-07-06
WO2001001152A9 (en) 2002-05-02
US20020010553A1 (en) 2002-01-24
CA2377528C (en) 2008-02-05
US6502040B2 (en) 2002-12-31
KR20020042539A (ko) 2002-06-05
ATE328327T1 (de) 2006-06-15
ES2270850T3 (es) 2007-04-16
DE60028374T2 (de) 2007-06-06
AU768436B2 (en) 2003-12-11
CA2377528A1 (en) 2001-01-04
AU6067600A (en) 2001-01-31
EP1188060A4 (en) 2005-04-13
EP1188060B1 (en) 2006-05-31
EP1188060A1 (en) 2002-03-20
WO2001001152A1 (en) 2001-01-04

Similar Documents

Publication Publication Date Title
Othman et al. Thromboelastography (teg)
Kamal et al. How to interpret and pursue an abnormal prothrombin time, activated partial thromboplastin time, and bleeding time in adults
US6101449A (en) Method for predicting the presence of congenital and therapeutic conditions from coagulation screening assays
Artang et al. Fully automated thromboelastograph TEG 6s to measure anticoagulant effects of direct oral anticoagulants in healthy male volunteers
Harrison et al. Screening tests of platelet function: update on their appropriate uses for diagnostic testing
US6321164B1 (en) Method and apparatus for predicting the presence of an abnormal level of one or more proteins in the clotting cascade
AU774889B2 (en) A method and apparatus for predicting the presence of haemostatic dysfunction in a patient sample
KR20020042622A (ko) 전혈내 응고 인자 활성을 측정하는 방법
US6898532B1 (en) Method and apparatus for predicting the presence of haemostatic dysfunction in a patient sample
de Laat-Kremers et al. Deciphered coagulation profile to diagnose the antiphospholipid syndrome using artificial intelligence
CA2377528C (en) Method and apparatus for presenting thrombosis and hemostasis assay data
Dempfle et al. Sensitivity and specificity of a quantitative point of care D-dimer assay using heparinized whole blood, in patients with clinically suspected deep vein thrombosis
Pîrlog et al. The applicability of thromboelastography in acute ischemic stroke: a literature review
Fricke et al. A multicenter clinical evaluation of the Clot Signature Analyzer
Sunderji et al. Clinical impact of point-of-care vs laboratory measurement of anticoagulation
AU2004201011B2 (en) Method and apparatus for presenting thrombosis and hemostasis assay data
Ofek et al. International normalized ratio as a screening test for assessment of anticoagulant activity for patients treated with rivaroxaban or apixaban: a pilot study
Mirus et al. Effects of pneumatic tube systems on viscoelastic coagulation tests in septic patients and healthy individuals: protocol of the randomized controlled VETaPT-trial
Givens et al. Classification of factor deficiencies from coagulation assays using neural networks
Sorrentino et al. Measuring Direct Oral Anticoagulant Levels in Laboratory Practice: Impact of Different Storage Conditions of Blood Samples
Maher et al. Case-control study of clotting differences using ROTEM testing in pregnant patients with early vaginal bleeding
Cook et al. Laboratory Instrumentation, Reagents, Methods, and Patient Sample as Variables in Coagulation
Price Point of care testing in haematology
EP1522860A1 (en) A method and apparatus for predicting the presence of haemostatic dysfunction in a patient sample
Training et al. Step 2: Getting a good drop of blood

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20050513

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20050513

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070509

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070509

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20100212

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100219

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20100713